Company Filing History:
Years Active: 2011-2022
Title: The Innovative Mind of Daniel Shin-Yu Chen
Introduction
Daniel Shin-Yu Chen is an accomplished inventor based in Burlingame, California, recognized for his contributions to the field of biomedical innovations. With two patents to his name, he is making strides in research that could impact treatment methodologies for various medical conditions.
Latest Patents
Chen's latest patents focus on critical advancements in cancer treatment. The first patent, titled "Biomarkers and methods of treating PD-1 and PD-L1 related conditions," provides essential biomarkers for the treatment of pathological conditions, including cancer. This innovation emphasizes the use of PD-1/PD-L1 pathway antagonists, presenting methods for patient selection, prognosis in cancer, and therapeutic treatments alongside associated diagnostic kits.
His second patent, "MHC-antigen arrays for detection and characterization of immune responses," details a sophisticated method for profiling T cells concerning their antigen receptor expression. This method involves arranging cells on a substrate that binds to MHC-antigen complexes, enabling detailed characterization of their responsiveness to external stimuli in diverse microenvironments. This technology holds promise for improved understanding and treatment of immune-related disorders.
Career Highlights
Throughout his career, Daniel Shin-Yu Chen has gained valuable experience working with prestigious organizations, including Leland Stanford Junior University and Genentech, Inc. His involvement in these institutions has provided him with a strong foundation in research and innovation in the biomedical field.
Collaborations
Daniel's work has also involved collaborations with prominent colleagues such as Yoav Soen and Daniel Lewis Kraft. Their shared vision for advancing medical science has likely contributed to the development and enhancement of innovative solutions in their respective fields.
Conclusion
Daniel Shin-Yu Chen stands out as a remarkable inventor whose patents have the potential to revolutionize approaches to cancer treatment and immune response characterization. Through his dedication to research and innovation, he continues to contribute significantly to medical science, paving the way for future advancements that could improve patient outcomes across the globe.